Processa Pharmaceuticals SG&A Expense (TTM) Analysis

Processa Pharmaceuticals Inc (PCSA)

1.93 -0.16 (-7.66%) USD | NASDAQ | Jul 02, 16:00

1.96 +0.03 (+1.55%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2012. Upgrade now.

Date	Value
March 31, 2024	4.461M
December 31, 2023	5.669M
September 30, 2023	7.146M
June 30, 2023	9.05M
March 31, 2023	10.06M
December 31, 2022	8.765M
September 30, 2022	7.437M
June 30, 2022	5.855M
March 31, 2022	5.150M
December 31, 2021	4.682M
September 30, 2021	5.367M
June 30, 2021	4.452M
March 31, 2021	3.497M
December 31, 2020	3.264M
September 30, 2020	1.678M
June 30, 2020	1.674M
March 31, 2020	1.709M
December 31, 2019	1.622M
September 30, 2019	1.361M
June 30, 2019	1.393M
March 31, 2019	1.334M
December 31, 2018	1.406M
September 30, 2018	1.923M

Date	Value
June 30, 2018	1.635M
March 31, 2018	1.295M
December 31, 2017	0.8383M
September 30, 2017	0.1694M
June 30, 2017	0.01M
March 31, 2017	0.0031M
December 31, 2016	0.07M
September 30, 2016	0.128M
June 30, 2016	0.2078M
March 31, 2016	0.5665M
December 31, 2015	0.9455M
September 30, 2015	0.7306M
June 30, 2015	1.324M
March 31, 2015	1.674M
December 31, 2014	2.020M
September 30, 2014	2.947M
June 30, 2014	2.934M
March 31, 2014	2.887M
December 31, 2013	2.819M
September 30, 2013	2.741M
June 30, 2013	2.595M
March 31, 2013	2.230M
December 31, 2012	1.884M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

1.361M

Minimum

Sep 2019

10.06M

Maximum

Mar 2023

4.889M

Average

4.682M

Median

Dec 2021

SG&A Expense (TTM) Benchmarks